Electroacupuncture at ST36 to see if it lowers postoperative inflammation after heart surgery with bypass
Official title: Effect of Electroacupuncture at Bilateral Zusanli (ST36) on Postoperative Inflammatory Response and Organ Injury in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Prospective, Randomized, Parallel-Controlled Trial
Run by Sir Run Run Shaw Hospital · NCT07795112 · Data updated 2026-11-12
This trial tests whether bilateral ST36 electroacupuncture given after cardiac surgery with bypass can reduce inflammation and improve recovery compared with a sham procedure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Sir Run Run Shaw Hospital Academic / other |
| Drugs / interventions | prednisone |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | September 1, 2026 |
| Main results expected | February 1, 2027 |
| Study ends | May 1, 2027 |
| Registry record updated | September 8, 2026 |
| Trial ID | NCT07795112 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) scheduled for elective cardiac surgery with cardiopulmonary bypass who can consent.
✕Probably not a fit
Patients for whom inflammation is not driven by neuroimmune pathways or who do not respond to this intervention may see no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, parallel-group trial enrolling adults undergoing elective cardiac surgery with cardiopulmonary bypass. Participants are assigned after surgery to receive either bilateral ST36 electroacupuncture or a control procedure without electrical stimulation at the same acupoint, each session lasting 30 minutes and repeated twice. All participants receive standard postoperative care, and the primary outcomes include C-reactive protein levels and organ dysfunction scores on postoperative day 2. Secondary outcomes cover vasoactive drug use, inflammatory markers, mechanical ventilation, ICU/hospital length of stay, and other clinical indicators. The study aims to determine if electroacupuncture can modulate the systemic inflammatory response related to CPB and surgical trauma.
Why it matters
Potential benefit: If successful, this approach could reduce postoperative inflammation and potentially shorten recovery after cardiac surgery.
How similar studies have gone: Previous preclinical work suggests a potential anti-inflammatory effect of ST36 electroacupuncture, but clinical evidence in this setting is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years. * Scheduled to undergo elective cardiac surgery with cardiopulmonary bypass (CPB) support. * The surgical procedure may include coronary artery bypass grafting (CABG), valve replacement, valve repair, or another cardiac surgical procedure performed with CPB support. * Voluntarily agrees to participate in the study and provides written informed consent. If a participant is unable to read and sign the informed consent form because of incapacity or another reason, the informed consent process will be conducted with the participant's legally authorized representative, who will sign on the participant's behalf. If a participant is unable to read the informed consent form, the informed consent process will be witnessed by an independent witness, who will sign the informed consent form. Exclusion Criteria: * Membership in a vulnerable population other than older adults or individuals who are illiterate, including patients with psychiatric disorders, cognitive impairment, critical illness, or another vulnerable condition. * Pregnant or breastfeeding. * Local skin or soft-tissue infection, erysipelas, or another condition at the acupuncture site that makes acupuncture treatment unsuitable. * History of organ transplantation. * Active malignancy. * Long-term high-dose corticosteroid therapy before surgery, defined as prednisone ≥20 mg/day for ≥14 days or a cumulative prednisone-equivalent dose \>700 mg. * Severe chronic organ dysfunction before surgery, including any of the following: * Chronic respiratory disease with a baseline PaO₂/FiO₂ ratio \<300. * Hematological disease, such as leukemia, lymphoma, or myeloma, or a baseline platelet count \<100 × 10⁹/L. * Chronic liver disease with total bilirubin \>30 μmol/L. * History of stroke or cerebral hemorrhage with a baseline Glasgow Coma Scale score \<10. * Chronic renal insufficiency with serum creatinine \>110 μmol/L or long-term daily urine output \<500 mL. * Unable to tolerate electroacupuncture treatment. * Currently participating in another interventional clinical study. * Any other condition that, in the investigator's judgment, makes the patient unsuitable for participation.
Where it's running
-
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Ni Wei
- Email: 3323158@zju.edu.cn
- Phone: +8615868153275
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can Cardiac Cycle Efficiency predict high-dose vasoactive-inotropic needs after open-heart surgery?
This study tests whether Cardiac Cycle Efficiency measured after coming off bypass can predict which adults will need high doses of vasoactive and inotropic meds in the first 24 hours after open-heart surgery.
-
Ventilation During Transport of Mechanically Ventilated Patients After Non-Cardiac Surgery
This observational study looks at how patients who stay intubated after non-cardiac surgery are ventilated during the move from the operating room to the ICU.
-
Pupillometry to find children at risk for opioid-related breathing problems after tonsillectomy
This project will try to see if a quick, noninvasive pupillometry test can identify children having tonsillectomy who are likely to have opioid-related breathing problems after surgery.
-
Preoperative submaximal exercise testing to predict outcomes after moderate- to high-risk noncardiac surgery
This study will test whether a brief submaximal cardiopulmonary exercise test done before moderate- to high-risk noncardiac surgery can help predict which adults over 45 are more likely to have problems after surgery.
-
Global longitudinal strain to predict difficult separation from cardiopulmonary bypass
This will test whether a heart ultrasound measure called global longitudinal strain (GLS) can predict which adults having elective cardiac surgery will have trouble coming off cardiopulmonary bypass.
-
Aminophylline versus furosemide for urine output after adult heart surgery
This trial will test whether aminophylline or furosemide helps increase urine output and lower the chance of kidney injury in adults having planned cardiac surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.